Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.
Authors:
- A ScharlASA Scharl
- U ThelenUTU Thelen
- A AhrAAA Ahr
- G CrombachGCG Crombach
- B R TitiusBTB R Titius
- 1 January 1996
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 49 (1) , 57-64
Abstract
AIM: To test whether immunoradiometric or immunohistochemical detection of lysosomal protease cathepsin D in breast cancer is more predictive of outcome. METHODS: Tumour tissues from 270 primary breast cancer patients were evaluated for the expression of cathepsin D using immunohistochemistry (IH; paraffin embedded tissues) and an immunoradiometric assay (IRMA; cytosol from frozen tissues). Immunohistochemical scores were based on immunoreaction in tumour cells and tumour associated macrophages. RESULTS: IRMA values (cut off 40 fmol/mg cell protein) correlated significantly with IH values. Recorded incidences of positive immunoreaction in tumour cells using two different cut off values were 52% and 35%, respectively. Macrophages stained positive in 31% of tissues. Combined evaluation of tumour cells and macrophages resulted in positivity rates of 59% and 48%, respectively. Node status was the only variable found to correlate with cathepsin D expression. IH results correlated significantly with clinical outcome (median observation time 68 months) in node negative patients (n = 120) but not in node positive patients (n = 145). Cathepsin D positivity as measured by IRMA was not related to clinical outcome in either group. On multivariate analysis in the node negative group, IH detection of cathepsin D appeared to be the only independent factor indicating prognosis. For node positive patients, tumour grade, size, and receptor status were of prognostic relevance. CONCLUSIONS: Because of the simple methodology and the minimal amount of tissue used for analysis, immunohistochemistry was preferred to immunoradiometry for cathepsin D measurement; it also provided more predictive data with respect to prognosis.Keywords
This publication has 50 references indexed in Scilit:
- Prognostische Bedeutung von Kathepsin D beim primären MammakarzinomGeburtshilfe und Frauenheilkunde, 1994
- Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancerEuropean Journal of Cancer, 1994
- Cathepsin D in breast cancer: A tissue marker associated with metastasisEuropean Journal of Cancer, 1992
- Immunostaining of cathepsin D in breast cancer: Quantification by computerised image analysis and correlation with cytosolic assayEuropean Journal of Cancer, 1992
- Prognostic value of total cathepsin D in breast tumorsBreast Cancer Research and Treatment, 1991
- Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancersEuropean Journal of Cancer and Clinical Oncology, 1991
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancerJournal of Steroid Biochemistry, 1989
- Immunohistochemical distribution of the 52-kDa protein in mammary tumors: A marker associated with cell proliferation rather than with hormone responsivenessJournal of Steroid Biochemistry, 1987
- Estradiol induced proteins in the MCF7 human breast cancer cell lineBiochemical and Biophysical Research Communications, 1979